07:31 AM EST, 02/24/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday that interim trial data showed that an oral granule formulation of Orladeyo (berotralstat) demonstrated sustained reductions in monthly attack rates in pediatric patients aged 2 to less than 12 with hereditary angioedema. After taking Orladeyo for one month, median and mean monthly attack rates dropped to...

07:32 AM EST, 02/24/2025 (MT Newswires) -- Glaukos Corp ( GKOS ) said Monday that the US Food and Drug Administration has accepted its corneal disease drug Epioxa for review, with a goal date of Oct. 10. Epioxa is a corneal cross-linking iLink therapy for the treatment of keratoconus, a sight-threatening corneal disease. The application includes data from two phase...

07:31 AM EST, 02/24/2025 (MT Newswires) -- MAG Silver ( MAG ) on Monday gave an exploration update for its Larder project in Ontario and the Deer Trail carbonate replacement deposit in Utah. At Larder, the company said drilling at the Cadillac-Larder Break successfully extended the Cheminis and Bear zones to depths of 900 meters with 10.2 grams per tonne...

07:31 AM EST, 02/24/2025 (MT Newswires) -- The direction of United States protectionism will be the main driver beyond the short term, said ING. Markets should see the discussion on Mexico and Canada tariffs trade return to center stage as the deadline for the delayed tariffs is a week away, noted the bank. Canada is already disproportionately affected by U.S....